US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Direxion Daily S&P Biotech Bull 3x Shares

247.50

-2.1500-0.86%

Volume:180.81K

Turnover:45.76M

Market Cap:562.94M

PE:- -

High:259.01

Open:256.20

Low:247.14

Close:249.65

52wk High:341.93

52wk Low:95.98

Shares:2.27M

Float Shares:2.27M

Volume Ratio:2.12

T/O Rate:7.95%

Dividend:0.90

Dividend Rate:0.37%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Analysts Offer Insights on Healthcare Companies: Eledon Pharmaceuticals (ELDN), Viking Therapeutics (VKTX) and Amgen (AMGN)

China Isotope & Radiation Gains FDA Clearance for Lu-177 Nuclear Medicine Ingredient

Filana can proceed with study as hold lifted, says Lucid Capital

Compass Therapeutics Faces FDA Pushback on Tovecimig Trial

Press Release: Endovia Health Sciences Closes Initial Funding to Accelerate CannEpil(R) Development Amid Growing Federal Support for Botanical Drug Pathways

Jaguar Health receives fee waivers from FDA

Lantheus Says FDA Approves Cancer Drug

MT Newswires Live

Sector Update: Healthcare

MT Newswires Live

Press Release: Primrose Bio(R) Raises Significant Growth Capital Investment Led by Signet Healthcare Partners

AIM ImmunoTech Highlights Ampligen’s Potential Role in the Evolving Pancreatic Cancer Treatment Landscape Following FDA Approval of Revolution Medicines’ Daraxonrasib

Health Care Select Sector SPDR: Pivot points

Filana Therapeutics announces U.S. FDA lifted clinical hold on simufilam

Lantheus announces U.S. FDA granted final approval for Bravnesta

Natural design. Amplified: Smith+Nephew announces FDA 510(k) clearance and first surgical cases of LANDMARK™ Total Knee System

Decoy Therapeutics to explore pan-filovirus program via FDA Animal Rule pathway

Analysts’ Opinions Are Mixed on These Healthcare Stocks: CVRx (CVRX), Butterfly Network (BFLY) and Viridian Therapeutics (VRDN)

Analysts’ Opinions Are Mixed on These Healthcare Stocks: AnaptysBio (ANAB), Alkermes (ALKS) and Iradimed (IRMD)

Buy Rating Reiterated on Foralumab Data Catalysts, $7 Price Target Maintained

Analysts Offer Insights on Healthcare Companies: Amgen (AMGN), Invivyd (IVVD) and Humacyte (HUMA)

EPF Raises Stake in IHH Healthcare to 13.2%

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://hk.tigershowtime.com/stock/LABU/news?page=17"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"LABU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","market":"US","secType":"STK","nameCN":"Direxion Daily S&P Biotech Bull 3x Shares","latestPrice":247.5,"timestamp":1790953874512,"preClose":249.65,"halted":0,"volume":180813,"delay":0,"changeRate":-0.008612056879631506,"floatShares":2274486,"shares":2274486,"eps":0,"marketStatus":"Trading","change":-2.15,"latestTime":"10-02 11:11:17 EDT","open":256.195,"high":259.01,"low":247.14,"amount":45759633.29856,"amplitude":0.047547,"askPrice":248.65,"askSize":140,"bidPrice":247.69,"bidSize":10,"shortable":3,"etf":3,"ttmEps":0,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1790971200000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":249.65,"sharesOutstanding":3074486,"nav":265.086,"aum":616188302.35,"dividendRate":0.003651,"bidAskSpread":0.003421,"preHourTrading":{"tag":"盘前","latestPrice":256,"preClose":249.65,"latestTime":"09:27 EDT","volume":5553,"amount":1438964.4383999999,"timestamp":1790947678782,"change":6.35,"changeRate":0.025436,"amplitude":0.043381},"postHourTrading":{"tag":"盘后","latestPrice":251.75,"preClose":249.65,"latestTime":"19:59 EDT","volume":7054,"amount":1775509.5491,"timestamp":1790899181648,"change":2.1,"changeRate":0.008412,"amplitude":0.011416},"volumeRatio":2.115522,"impliedVol":0.9361,"impliedVolPercentile":0.5618},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","floatShares":2274486,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":2.115522,"shares":2274486,"dividePrice":0.9037,"high":259.01,"amplitude":0.047547,"preClose":249.65,"low":247.14,"week52Low":95.98,"pbRate":"--","week52High":341.93,"institutionHeld":0,"latestPrice":247.5,"committee":-0.866667,"eps":0,"divideRate":0.003651,"volume":180813,"delay":0,"ttmEps":0,"open":256.195,"prevYearClose":159.39,"prevWeekClose":252.47,"prevMonthClose":265.79,"prevQuarterClose":265.79,"fiveDayClose":252.47,"twentyDayClose":305.86,"sixtyDayClose":324.26},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/LABU\",params:#limit:5,,,undefined,":[{"date":"2025-09-23","symbol":"LABU","amount":0.10273,"announcedDate":"2025-09-22","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-23","defaultRemindTime":1758634200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-30","payableDate":"2025-09-23","currency":"USD","dateTimestamp":1758600000000,"payDate":"2025-09-30"},{"date":"2025-06-24","symbol":"LABU","amount":0.21897,"announcedDate":"2025-06-23","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-24","defaultRemindTime":1750771800000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-07-01","payableDate":"2025-06-24","currency":"USD","dateTimestamp":1750737600000,"payDate":"2025-07-01"},{"date":"2025-03-25","symbol":"LABU","amount":0.10714,"announcedDate":"2025-03-24","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-25","defaultRemindTime":1742909400000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-04-01","payableDate":"2025-03-25","currency":"USD","dateTimestamp":1742875200000,"payDate":"2025-04-01"},{"date":"2024-06-25","symbol":"LABU","amount":0.15021,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-06-25","defaultRemindTime":1719322200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-07-02","payableDate":"2024-06-25","currency":"USD","dateTimestamp":1719288000000,"payDate":"2024-07-02"},{"date":"2024-03-19","symbol":"LABU","amount":0.16064,"announcedDate":"2024-03-18","type":"dividend","market":"US","newRecordDate":"2024-03-20","defaultRemindTime":1710855000000,"name":"三倍做多标普生物-Direxion","recordDate":"2024-03-26","payableDate":"2024-03-20","currency":"USD","dateTimestamp":1710820800000,"payDate":"2024-03-26"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"LABU\",market:\"US\",,,undefined,":[{"executeDate":"2018-06-19","recordDate":"2018-06-20","paymentDate":"2018-06-26","value":0.01932,"currency":"USD"},{"executeDate":"2018-09-25","recordDate":"2018-09-26","paymentDate":"2018-10-02","value":0.0954,"currency":"USD"},{"executeDate":"2018-12-27","recordDate":"2018-12-28","paymentDate":"2019-01-04","value":0.09621,"currency":"USD"},{"executeDate":"2019-03-19","recordDate":"2019-03-20","paymentDate":"2019-03-26","value":0.10973,"currency":"USD"},{"executeDate":"2019-06-25","recordDate":"2019-06-26","paymentDate":"2019-07-02","value":0.03745,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"LABU\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"LABU\",pageSize:20,pageCount:17,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2669757123","title":"Analysts Offer Insights on Healthcare Companies: Eledon Pharmaceuticals (ELDN), Viking Therapeutics (VKTX) and Amgen (AMGN)","url":"https://stock-news.laohu8.com/highlight/detail?id=2669757123","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669757123?lang=en_us&edition=fundamental","pubTime":"2026-09-22 23:20","pubTimestamp":1790090418,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Eledon Pharmaceuticals (ELDN), Viking Therapeutics (...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-eledon-pharmaceuticals-eldn-viking-therapeutics-vktx-and-amgen-amgn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-eledon-pharmaceuticals-eldn-viking-therapeutics-vktx-and-amgen-amgn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PBE","LU2089984988.USD","LU2242646821.SGD","LU0128526141.USD","IE00B2B36J28.USD","LU0029874061.USD","BK4139","LU0122379950.USD","IE00B4R5TH58.HKD","LU0320765992.SGD","HCSG","BIB","LU2468319806.SGD","BK4534","IBB","BK4588","LU0058720904.USD","IE0002141913.USD","ELDN","LU0289739699.SGD","LU1061106388.HKD","LU1571399168.USD","BK4566","IE00BFTCPJ56.SGD","LU1057294990.SGD","XLV","BBH","PJP","IE00BJJMRZ35.SGD","LU2112291526.USD","IE0009355771.USD","BK4585","LU0109394709.USD","AMGN","LU0889565916.HKD","BK4533","TBXU","BK4599","SG9999001440.SGD","LU1983299246.USD","LU2242652126.USD","BK4137","LABU","IBBQ","OZEM","VKTX","LU0868494617.USD","IE00BJT1NW94.SGD","XBI","THNR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669128984","title":"China Isotope & Radiation Gains FDA Clearance for Lu-177 Nuclear Medicine Ingredient","url":"https://stock-news.laohu8.com/highlight/detail?id=2669128984","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669128984?lang=en_us&edition=fundamental","pubTime":"2026-09-22 22:38","pubTimestamp":1790087888,"startTime":"0","endTime":"0","summary":"China Isotope & Radiation Corp. ( ($HK:1763) ) has provided an announcement. China Isotope & Radiation Corporation has announced that its subsidiar...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/china-isotope-radiation-gains-fda-clearance-for-lu-177-nuclear-medicine-ingredient?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/china-isotope-radiation-gains-fda-clearance-for-lu-177-nuclear-medicine-ingredient?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","LABU","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669140714","title":"Filana can proceed with study as hold lifted, says Lucid Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2669140714","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669140714?lang=en_us&edition=fundamental","pubTime":"2026-09-22 22:05","pubTimestamp":1790085948,"startTime":"0","endTime":"0","summary":"Lucid Capital analyst Elemer Piros reiterates a Buy rating on Filana Therapeutics (FLNA) with an $8 price target after the company said the FDA has...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/filana-can-proceed-with-study-as-hold-lifted-says-lucid-capital-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/filana-can-proceed-with-study-as-hold-lifted-says-lucid-capital-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4596","LCID","FLNA","BK4099","BK4551","BK4585","BK4007","BK4555","LCDL","LCIZ","BK4588","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669474981","title":"Compass Therapeutics Faces FDA Pushback on Tovecimig Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2669474981","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669474981?lang=en_us&edition=fundamental","pubTime":"2026-09-22 21:35","pubTimestamp":1790084121,"startTime":"0","endTime":"0","summary":"The latest update is out from Compass Therapeutics ( ($CMPX) ). On Sept. 22, 2026, Compass Therapeutics reported that the U.S. Food and Drug Admini...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/compass-therapeutics-faces-fda-pushback-on-tovecimig-trial?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/compass-therapeutics-faces-fda-pushback-on-tovecimig-trial?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CMPX","BK4139","BK4588","BK4585","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669714767","title":"Press Release: Endovia Health Sciences Closes Initial Funding to Accelerate CannEpil(R) Development Amid Growing Federal Support for Botanical Drug Pathways","url":"https://stock-news.laohu8.com/highlight/detail?id=2669714767","media":"Dow Jones","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669714767?lang=en_us&edition=fundamental","pubTime":"2026-09-22 21:30","pubTimestamp":1790083800,"startTime":"0","endTime":"0","summary":"Initial tranche assists CannEpil(R) development and commercializationFinancing comes as FDA and Congress increase focus on advancing and incentivizing regulated development of botanical and plant-deri","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TLTW","BK4585","US30Y.BOND","US10Y.BOND","EDVA","TMF","BK4588","US7Y.BOND","US6M.BOND","AAQC","R","BK4169","BK4232","TLT","LABU","US2Y.BOND","US3Y.BOND","BK4022","US12M.BOND","US5Y.BOND"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669474031","title":"Jaguar Health receives fee waivers from FDA","url":"https://stock-news.laohu8.com/highlight/detail?id=2669474031","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669474031?lang=en_us&edition=fundamental","pubTime":"2026-09-22 21:20","pubTimestamp":1790083211,"startTime":"0","endTime":"0","summary":"Jaguar Health’s (JAGX) Napo Pharmaceuticals announced that the U.S. Food and Drug Administration has granted Napo’s request for a waiver of the fee...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/jaguar-health-receives-fee-waivers-from-fda-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/jaguar-health-receives-fee-waivers-from-fda-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU","BK4007","BK4585","JAGX","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669142710","title":"Lantheus Says FDA Approves Cancer Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2669142710","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669142710?lang=en_us&edition=fundamental","pubTime":"2026-09-22 21:07","pubTimestamp":1790082447,"startTime":"0","endTime":"0","summary":"Lantheus (LNTH) said Tuesday that the US Food and Drug Administration granted final approval for Bravnetsa, a radiopharmaceutical equivalent to Lutathera, for adults with gastroenteropancreatic neuroe","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LABU","BK4585","LNTH","BK4198","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669935142","title":"Sector Update: Healthcare","url":"https://stock-news.laohu8.com/highlight/detail?id=2669935142","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669935142?lang=en_us&edition=fundamental","pubTime":"2026-09-22 21:00","pubTimestamp":1790082001,"startTime":"0","endTime":"0","summary":"Healthcare stocks were mixed pre-bell Tuesday, with the State Street Health Care Select Sector SPDR ETF  0.2% lower and the iShares Biotechnology ETF  up 0.6%.Viking Therapeutics  shares were up more than 23% after the company said its subcutaneous VK2735 showed \"superior weight maintenance\" under less frequent dosing regiments compared to placebo over a 12-week period in a clinical study.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4585","BK4599","BK4588","HCSG","BK4139","IBB","OZEM","BK4137","LABU","BK4581","VKTX","LU0029874061.USD","LU0128526141.USD","XLV","XBI","THNR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669421791","title":"Press Release: Primrose Bio(R) Raises Significant Growth Capital Investment Led by Signet Healthcare Partners","url":"https://stock-news.laohu8.com/highlight/detail?id=2669421791","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669421791?lang=en_us&edition=fundamental","pubTime":"2026-09-22 21:00","pubTimestamp":1790082000,"startTime":"0","endTime":"0","summary":"SAN DIEGO, Sept. 22, 2026 /PRNewswire/ -- Primrose Bio, Inc. , a provider of production solutions for next-generation biologics, today announced the closing of a financing round led by new investor Signet Healthcare Partners , with significant participation from existing investors 1315 Capital, Ligand Pharmaceuticals Incorporated , LDV Partners, and Agent Capital. In conjunction with the financing, James Gale, Founding Partner and Managing Director of Signet, has joined Primrose's Board of Directors.The proceeds will help Primrose continue to expand the reach and capabilities of its differentiated technology portfolio:-- Pfenex Expression Technology , a scalable microbial. expression platform for efficient, high-yield production of complex,-- Prima RNApols, proprietary RNA polymerases for consistent, scalable,-- PeliCRM197, a validated carrier protein used in multiple approved","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4022","LU0128526141.USD","LABU","XLV","BK4581","LGND","BK4137","BK4585","LU0566484027.USD","BK4588","BK4139","BK4232","R","LU1559883803.SGD","BK4007","HCSG","HELX","XBI","LU0029874061.USD","IE0009354923.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669142210","title":"AIM ImmunoTech Highlights Ampligen’s Potential Role in the Evolving Pancreatic Cancer Treatment Landscape Following FDA Approval of Revolution Medicines’ Daraxonrasib","url":"https://stock-news.laohu8.com/highlight/detail?id=2669142210","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669142210?lang=en_us&edition=fundamental","pubTime":"2026-09-22 20:55","pubTimestamp":1790081700,"startTime":"0","endTime":"0","summary":"Daraxonrasib is an important therapeutic advance, but pancreatic cancer is not a simple disease where one successful targeted drug makes additional therapeutic development unnecessary. We believe Ampligen has the potential to complement and extend therapies such as daraxonrasib by helping to overcome the immune biological barriers that have h","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/22/3366375/29489/en/aim-immunotech-highlights-ampligen-s-potential-role-in-the-evolving-pancreatic-cancer-treatment-landscape-following-fda-approval-of-revolution-medicines-daraxonrasib.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IDNA","IE00BFTCPJ56.SGD","PTH","LABU","BBH","BK4585","BK4139","CANC","LU0889565916.HKD","IE0009354923.USD","IE00BJT1NW94.SGD","IE0009355771.USD","IE00B2B36J28.USD","IE0002141913.USD","IE00B4R5TH58.HKD","LU0320765992.SGD","RVMD","BK4588","IE00BJJMRZ35.SGD","LU0109394709.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669797144","title":"Health Care Select Sector SPDR: Pivot points","url":"https://stock-news.laohu8.com/highlight/detail?id=2669797144","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669797144?lang=en_us&edition=fundamental","pubTime":"2026-09-22 20:25","pubTimestamp":1790079948,"startTime":"0","endTime":"0","summary":"The following are the pivot points for the Health Care Select Sector SPDR (XLV). Pivot High: $170.61, Pivot Low: $167.93. These were calculated usi...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/health-care-select-sector-spdr-pivot-points-thefly-news-147?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/health-care-select-sector-spdr-pivot-points-thefly-news-147?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4581","BK4585","BK4588","LABU","XBI","XLV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669442921","title":"Filana Therapeutics announces U.S. FDA lifted clinical hold on simufilam","url":"https://stock-news.laohu8.com/highlight/detail?id=2669442921","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669442921?lang=en_us&edition=fundamental","pubTime":"2026-09-22 20:20","pubTimestamp":1790079649,"startTime":"0","endTime":"0","summary":"Filana Therapeutics (FLNA) announced that the U.S. Food and Drug Administration, FDA, has lifted the clinical hold on the Company’s investigational...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/filana-therapeutics-announces-u-s-fda-lifted-clinical-hold-on-simufilam-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/filana-therapeutics-announces-u-s-fda-lifted-clinical-hold-on-simufilam-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","SYNB","FLNA","BK4007","IBB","BK4585","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669328144","title":"Lantheus announces U.S. FDA granted final approval for Bravnesta","url":"https://stock-news.laohu8.com/highlight/detail?id=2669328144","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669328144?lang=en_us&edition=fundamental","pubTime":"2026-09-22 20:15","pubTimestamp":1790079345,"startTime":"0","endTime":"0","summary":"Lantheus (LNTH) announced that the U.S. Food and Drug Administration, FDA, has granted final approval for Bravnesta, a bioequivalent and therapeuti...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/lantheus-announces-u-s-fda-granted-final-approval-for-bravnesta-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/lantheus-announces-u-s-fda-granted-final-approval-for-bravnesta-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU","LNTH","BK4588","BK4198","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669890142","title":"Natural design. Amplified: Smith+Nephew announces FDA 510(k) clearance and first surgical cases of LANDMARK™ Total Knee System","url":"https://stock-news.laohu8.com/highlight/detail?id=2669890142","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669890142?lang=en_us&edition=fundamental","pubTime":"2026-09-22 20:00","pubTimestamp":1790078400,"startTime":"0","endTime":"0","summary":"Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces it received 510(k) clearance from the U.S. Food and Drug Administration (FDA) and has completed the first surgic","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/22/3366242/0/en/natural-design-amplified-smith-nephew-announces-fda-510-k-clearance-and-first-surgical-cases-of-landmark-total-knee-system.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4144","BK4588","LABU","TSS","BK4585","ASC","BK4082","SNN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669149210","title":"Decoy Therapeutics to explore pan-filovirus program via FDA Animal Rule pathway","url":"https://stock-news.laohu8.com/highlight/detail?id=2669149210","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669149210?lang=en_us&edition=fundamental","pubTime":"2026-09-22 19:35","pubTimestamp":1790076909,"startTime":"0","endTime":"0","summary":"Decoy Therapeutics (DCOY) announced a corporate strategy to explore its Designable Multi-Antivirals, or D-MAVs, for additional candidates, includin...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/decoy-therapeutics-to-explore-pan-filovirus-program-via-fda-animal-rule-pathway-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/decoy-therapeutics-to-explore-pan-filovirus-program-via-fda-animal-rule-pathway-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","BK4139","DCOY","LABU","BK4007","LENZ","BK4585","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669149323","title":"Analysts’ Opinions Are Mixed on These Healthcare Stocks: CVRx (CVRX), Butterfly Network (BFLY) and Viridian Therapeutics (VRDN)","url":"https://stock-news.laohu8.com/highlight/detail?id=2669149323","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669149323?lang=en_us&edition=fundamental","pubTime":"2026-09-22 19:10","pubTimestamp":1790075417,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on CVRx (CVRX), Butterfly Network (BFLY) and Viridian Therapeutics (...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-cvrx-cvrx-butterfly-network-bfly-and-viridian-therapeutics-vrdn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-cvrx-cvrx-butterfly-network-bfly-and-viridian-therapeutics-vrdn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BFLY","LU0029874061.USD","BK4137","LABU","BK4585","BK4539","XLV","BK4139","VRDN","LU0128526141.USD","BK4082","HCSG","CVRX","BK4588","XBI","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669678146","title":"Analysts’ Opinions Are Mixed on These Healthcare Stocks: AnaptysBio (ANAB), Alkermes (ALKS) and Iradimed (IRMD)","url":"https://stock-news.laohu8.com/highlight/detail?id=2669678146","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669678146?lang=en_us&edition=fundamental","pubTime":"2026-09-22 18:50","pubTimestamp":1790074221,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on AnaptysBio (ANAB), Alkermes (ALKS) and Iradimed (IRMD). AnaptysBi...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-anaptysbio-anab-alkermes-alks-and-iradimed-irmd-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-anaptysbio-anab-alkermes-alks-and-iradimed-irmd-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PSIL","ALKS","BK4137","XLV","PSCH","BK4588","LABU","XBI","LU0029874061.USD","MEDX","FFTY","IRMD","BK4139","FBT","LU0128526141.USD","BK4581","BK4082","BK4585","HCSG","IBRN","ANAB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669143053","title":"Buy Rating Reiterated on Foralumab Data Catalysts, $7 Price Target Maintained","url":"https://stock-news.laohu8.com/highlight/detail?id=2669143053","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669143053?lang=en_us&edition=fundamental","pubTime":"2026-09-22 18:15","pubTimestamp":1790072132,"startTime":"0","endTime":"0","summary":"Tiziana Life Sciences, the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Thomas Shrader from BTIG maintained...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/buy-rating-reiterated-on-foralumab-data-catalysts-7-price-target-maintained-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/buy-rating-reiterated-on-foralumab-data-catalysts-7-price-target-maintained-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","XLV","LABU","BK4581","BK4585","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669143096","title":"Analysts Offer Insights on Healthcare Companies: Amgen (AMGN), Invivyd (IVVD) and Humacyte (HUMA)","url":"https://stock-news.laohu8.com/highlight/detail?id=2669143096","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669143096?lang=en_us&edition=fundamental","pubTime":"2026-09-22 18:10","pubTimestamp":1790071809,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Amgen (AMGN), Invivyd (IVVD) and Humacyte (HUMA). ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-amgen-amgn-invivyd-ivvd-and-humacyte-huma-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-amgen-amgn-invivyd-ivvd-and-humacyte-huma-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PJP","IBB","IE0009355771.USD","LU2242646821.SGD","LU0889565916.HKD","HUMA","BK4563","IE00B2B36J28.USD","LU0109394709.USD","LU2468319806.SGD","LU2089984988.USD","AMGN","LU1057294990.SGD","XBI","LU1571399168.USD","BBH","BK4139","BK4539","LU0128526141.USD","LU1983299246.USD","LU0868494617.USD","TBXU","BK4137","IE0002141913.USD","LU2242652126.USD","LABU","BK4534","SG9999001440.SGD","BK4599","XLV","IE00BJJMRZ35.SGD","IE00BFTCPJ56.SGD","PBE","IE00BJT1NW94.SGD","BK4566","BK4533","IVVD","LU1023059063.AUD","LU0058720904.USD","LU0122379950.USD","IBBQ","LU0029874061.USD","BIB","LU1061106388.HKD","BK4588","IE00B4R5TH58.HKD","HCSG","LU0289739699.SGD","LU0320765992.SGD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669143323","title":"EPF Raises Stake in IHH Healthcare to 13.2%","url":"https://stock-news.laohu8.com/highlight/detail?id=2669143323","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669143323?lang=en_us&edition=fundamental","pubTime":"2026-09-22 17:47","pubTimestamp":1790070467,"startTime":"0","endTime":"0","summary":"An update from IHH Healthcare Bhd ( ($IHHHF) ) is now available. Malaysia’s Employees Provident Fund Board (EPF), a substantial shareholder in IHH ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/epf-raises-stake-in-ihh-healthcare-to-13-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/epf-raises-stake-in-ihh-healthcare-to-13-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XBI","BK4585","BK4581","HCSG","XLV","LU0128526141.USD","LU0029874061.USD","LABU","BK4588","BK4137"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":20,"pageCount":17,"totalSize":392,"code":"91000000","status":"200"}]}}